← Eichor
Study identifier: NCT07362511 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Imagery Rescripting in Primary Care

Condition: Major Depressive Diorder · Low Self-Esteem · Mood Disorders  ·  Sponsor: University of Amsterdam

PhaseNA
Planned participants12
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

In the current study we aim to investigate the feasibility, acceptability, and effectiveness of ImRs offered by mental health assistants within primary care to reduce depressive symptoms. In a single-case experimental design (SCED) study, the following hypotheses will be tested: 1. ImRs results in a reduction of depressive symptoms compared to baseline, and this reduction lasts up to six months. 2. Patients with complaints of depressive symptoms find ImRs an acceptable form of intervention when offered by mental health assistants within a general practice setting. Participants will wait for 2-4 weeks and then receive 5 sessions of ImRs over a period of 10 weeks. During these sessions, negative memories related to their depressed feelings are rescripted.

This description comes directly from the study's public registry record.

Talk to the study team

Lotte Stemerding  ·  0031614401653  ·  l.e.stemerding@uva.nl

Always discuss trial participation with your own doctor first.

Locations (1)

UvA HuisartsenAmsterdam, North Holland, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07362511